Keywords: Pfizer, Bosulif, Bosutinib, Rare leukemia, Ph+, CML, USA, FDA

FDA nod for Pfizer's rare leukemia drug Bosulif

Article | 06 September 2012

Print This

In a third cancer drug approval in just over a year for drugs behemoth Pfizer (NYSE: PFE), the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in